Alghamdi Faisal, Chan Michael
aDivision of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute bDivision of Cardiology, Royal Alexandra Hospital, University of Alberta, Edmonton, Alberta, Canada.
Curr Opin Cardiol. 2017 Mar;32(2):217-223. doi: 10.1097/HCO.0000000000000375.
Heart failure is a major chronic illness with no definitive cure. With improving healthcare and with an aging population in many countries, heart failure has become a common disease of the elderly. Pharmacological management of heart failure in the elderly remains a challenge. The syndrome of heart failure cannot be isolated from other comorbidities, which are very common in this population. The purpose of this review is to assist practicing clinicians to more effectively make decisions about management of heart failure in the elderly.
In this review, we will try to integrate recent research studies, recent guidelines, and new treatment modalities, and discuss some controversies.
In general, the elderly patient with heart failure should be treated according to current heart failure guidelines; however, untailored heart failure management may cause untoward effects in this age group and may worsen clinical outcome.
心力衰竭是一种主要的慢性疾病，尚无确切治愈方法。随着医疗保健水平的提高以及许多国家人口老龄化，心力衰竭已成为老年人的常见疾病。老年人心力衰竭的药物治疗仍然是一项挑战。心力衰竭综合征不能与其他合并症相分离，而这些合并症在该人群中非常常见。本综述的目的是帮助临床医生更有效地做出关于老年人心力衰竭管理的决策。
在本综述中，我们将尝试整合近期的研究、最新指南和新的治疗方式，并讨论一些争议点。
一般来说，老年心力衰竭患者应根据当前的心力衰竭指南进行治疗；然而，未经调整的心力衰竭管理可能会在这个年龄组中产生不良影响，并可能使临床结果恶化。
